ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselNOUSCOM AG
NOUSCOM AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Nouscom is the development of cancer vaccines, in particular neoantigen-based cancer vaccines for tumors with microsatellite instability.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

NOUSCOM AG

✓ Offered4
Neoantigen-Based Cancer Immunotherapies
Cancer immunotherapies using viral vectors and neoantigens, including an off-the-shelf therapy for dMMR/MSI tumors and a personalized neoantigen vaccine.
Personalized Cancer Vaccines
Personalized cancer vaccines based on patient-specific neoantigens from tumor mutanomes, with rapid manufacturing from biopsy to released product.
Off-the-Shelf Cancer Immunotherapies
Standardized cancer immunotherapies with shared frameshift neoantigens for dMMR/MSI tumors, used in combination with pembrolizumab and in clinical studies.
Targeted Oncolytic Viruses
Targeted armed oncolytic viruses for solid tumors, delivered locally or systemically, with immunomodulatory transgenes to enhance anti-tumor activity.
Trust & reputation

ranQ Trust Score of NOUSCOM AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

NOUSCOM AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
NOUSCOM AG scores 87.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.89.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
NOUSCOM AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
NOUSCOM AG scores 68.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.80.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.56.74%
Qualifications+0.00

NOUSCOM AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

May 9, 2025Media
Milestones achievements for life sciences startups
startupticker.ch
March 26, 2024Media
Nouscom secures additional funding from Angelini Ventures
startupticker.ch
November 14, 2023Media
Nouscom raises CHF65 million in oversubscribed Series C financing round
startupticker.ch
February 27, 2020Media
New bosses for life sciences companies
startupticker.ch
May 17, 2016Media
New company of former Okairos founders bags €12 million
startupticker.ch

Knowledge

No knowledge articles yet

Once NOUSCOM AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NOUSCOM AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NOUSCOM AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NOUSCOM AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bäumleingasse 18
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-243.080.729
Founded
2015 · 11 years
Last commercial register change
September 4, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    PA
    PharmaTrail AG
    Basel
    SB
    SOTIO Biotech AG
    Basel
    MS
    Moderna Switzerland GmbH
    Basel
    FA
    FimmCyte AG
    Basel
    CL
    Caris Life Sciences Switzerland Holdings GmbH
    Basel
    FT
    FoRx Therapeutics AG
    Basel
    BG
    BioBalletTech GmbH
    Riehen
    SC
    St. Clara Forschung AG
    Basel